DEA Schedule CIV
Strength
37.5 mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534015901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205017On Market Since
1/24/2017
Pharmacological Classes
Related Drugs
Same classification
NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203003•Taro Pharmaceuticals U.S.A. Inc.
$0.0678
per ML
PHENTERMINE 37.5 MG TABLET
Generic
10702002501•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
10702002510•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
43547040410•Solco Healthcare US LLC
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
43547040411•Solco Healthcare US LLC
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
53489067601•Sun Pharmaceutical Industries Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
53489067610•Sun Pharmaceutical Industries Inc.
$0.0694
per EA